A strong quarter for Essilor
Monday, November 3 2014 | 00 h 00 min | Financial News
Essilor’s revenue rose to CA$159 million in the third quarter of 2014, a 145% increase over the same period last year In North America, sales...
Read MoreValeant increases offer for Allergan
Monday, November 3 2014 | 00 h 00 min | Acquisitions
Quebec-based Valeant Pharmaceuticals has increased its takeover bid for Allergan from US$50 to nearly US$60 billion In a letter to Allergan, Valeant...
Read MoreTough quarter for Johnson & Johnson in the eye care market
Monday, November 3 2014 | 00 h 00 min | Financial News
Despite a good quarter for the company in general (sales of US$185 billion, up by 51% over last year), Johnson & Johnson reported a drop in eye...
Read MoreAllergan CEO honoured
Monday, November 3 2014 | 00 h 00 min | Latest News
Allergan CEO David Pyott was ranked the fourth best-performing CEO in the world by Harvard Business Review He was one of 832 CEOs from 30 countries...
Read MoreExcellent third quarter for Valeant
Monday, November 3 2014 | 00 h 00 min | Financial News
Quebec-based Valeant Pharmaceuticals, owner of Bausch + Lomb, among others, recorded its second best quarterly results since it was founded in...
Read More